Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/24/2011US20110288045 Wet granulation of tenofovir, emtricitabine and efavirenz
11/24/2011US20110288041 Antibacterial aminoglycoside analogs
11/24/2011US20110288040 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
11/24/2011US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011US20110288008 Antibacterial and plasmid elimination agents
11/24/2011US20110288007 Biocidal fusion peptide comprising ll-37
11/24/2011US20110288006 Peptides and methods for inducing cell death
11/24/2011US20110287410 Hepatitis-c virus testing
11/24/2011US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
11/24/2011US20110287083 Bioabsorbable Composition and Coatings Including Same
11/24/2011US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same
11/24/2011US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers
11/24/2011US20110287059 Honey analysis
11/24/2011US20110287054 Multivalent adjuvanted influenza virus compositions
11/24/2011US20110287052 Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
11/24/2011US20110287051 Parapoxvirus vectors
11/24/2011US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
11/24/2011US20110287048 Antigen Specific Tregs and related compositions, methods and systems
11/24/2011US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011US20110287045 Enhanced immune response against infections
11/24/2011US20110287044 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv
11/24/2011US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
11/24/2011US20110287040 Materials and methods for treatment of inflammation
11/24/2011US20110287039 Expression system for modulating an immune response
11/24/2011US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
11/24/2011US20110287019 Therapeutic targeting of escort proteins
11/24/2011US20110287013 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
11/24/2011US20110286996 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
11/24/2011US20110286971 Targeted drug-carrying bacteriophages
11/24/2011US20110286969 Deuterated compounds as hepatitis c virus (hcv) inhibitors
11/24/2011US20110286968 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/24/2011US20110286967 Long-acting interferons and derivatives thereof and methods thereof
11/24/2011US20110286965 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011US20110286962 Compounds and pharmaceutical compositions for the treatment of viral infections
11/24/2011US20110286961 Hepatitis C Virus Inhibitors
11/24/2011US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011US20110286945 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging
11/24/2011US20110286926 Degradable hydrogel compositions and methods
11/24/2011US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011CA2799878A1 Identifying antifungal agents that inhibit iaa or a yap family member
11/24/2011CA2799767A1 Latent human immunodeficiency virus reactivation
11/24/2011CA2799762A1 Crystalline hydrochloride salt of darunavir
11/24/2011CA2799531A1 Methods of treating recurring bacterial infection
11/24/2011CA2799393A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects
11/24/2011CA2799386A1 Treatment of clostridium difficile infection in patients undergoing antibiotic therapy
11/23/2011EP2388330A1 Liver engrafting cells, assays, and uses thereof
11/23/2011EP2388250A1 4-Pyrimidinone derivatives and their use as anti-HIV agents
11/23/2011EP2388249A1 HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
11/23/2011EP2387584A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins
11/23/2011EP2387583A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof
11/23/2011EP2387564A1 Benzo ýc¨phenanthridines as antimicrobial agents
11/23/2011EP2387417A2 Broad spectrum vaccine against non-typhoidal salmonella
11/23/2011EP2387409A1 Chitosan derivatives alone or in combination for the treatment of mdr microbial infections
11/23/2011EP2387398A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
11/23/2011EP2387396A1 Agent for preventing and treating pityriasis versicolor
11/23/2011EP2127667B1 Oral disinfectant and food additive comprising the disinfectant
11/23/2011EP2065377B1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
11/23/2011EP1943221B1 Piperazine amidines as antiviral agents
11/23/2011EP1866319B1 Phosphono-pent-2-en-1-yl nucleosides and analogs
11/23/2011EP1819700B1 Potassium salt of an hiv integrase inhibitor
11/23/2011EP1727558B1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents
11/23/2011EP1531841B1 Probiotics for gut neuromuscular functions
11/23/2011EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011EP1296715B1 Multivalent vaccine composition
11/23/2011EP1226148B1 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
11/23/2011CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions
11/23/2011CN1832960B Immunomodulating compositions, uses therefor and processes for their production
11/23/2011CN102257140A Treating hepatitis c virus infection with over-expression of microrna-196
11/23/2011CN102256991A Uracyl cyclopropyl nucleotides
11/23/2011CN102256989A Anionic conjugates of glycosylated bacterial metabolite
11/23/2011CN102256968A Heterocyclic antiviral compounds
11/23/2011CN102256951A Certain crystalline hydrates,pharmaceutical compositions thereof and methods for preparation and use thereof
11/23/2011CN102256942A New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
11/23/2011CN102256941A New salts
11/23/2011CN102256491A Isoxazole derivatives for use as fungicides
11/23/2011CN102250918A Recombinant human interferon-like proteins
11/23/2011CN102250916A Brown croaker chemotactic factor CC gene, and detection method and application thereof
11/23/2011CN102250915A Miichthys miiuy alpha chemokine gene CXCL10 as well as detection method and application thereof
11/23/2011CN102250843A Genetic engineering marked attenuated vaccine strain of porcine reproductive and respiratory syndrome virus and application thereof
11/23/2011CN102250817A Bacillus coagulans for feeding and application thereof
11/23/2011CN102250735A Propolis wine combined with golden camellia and preparation method thereof
11/23/2011CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof
11/23/2011CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof
11/23/2011CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound
11/23/2011CN102250255A Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof
11/23/2011CN102250239A Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof
11/23/2011CN102250234A Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof
11/23/2011CN102250225A Antimicrobial polyperptides from pseudoplectania nigrella
11/23/2011CN102250221A Vancomycin derivate, and preparation method and application thereof
11/23/2011CN102250216A Rana nigromaculata antimicrobial peptide as well as gene and application thereof
11/23/2011CN102250181A Polyhydroxy steroid compounds and purpose thereof
11/23/2011CN102250174A Method for extracting jasminin from winter jasmine leaves
11/23/2011CN102250170A Preparation method and application of two active flavonoid glycosides in okra fruits
11/23/2011CN102250142A Andrographolide compound and application of andrographolide compound in medicaments
11/23/2011CN102250123A Cefodizime sodium hydrate as well as preparation method and application thereof